Target Name: POLR1D
NCBI ID: G51082
Review Report on POLR1D Target / Biomarker Content of Review Report on POLR1D Target / Biomarker
POLR1D
Other Name(s): RPO1-3 | POLR1C | RNA polymerase I 16 kDa subunit | POLR1D variant 1 | RPAC2_HUMAN | RNA polymerase I subunit D | RNA polymerases I and III subunit AC2 | RPAC2 | RPA9 | TCS2 | DNA-directed RNA polymerases I and III subunit RPAC2 | OTTHUMP00000018171 | RNA polymerase I and III subunit D | polymerase (RNA) I polypeptide D, 16kDa | RPA16 | RNA polymerase I and III subunit D, transcript variant 1 | MGC9850 | AC19 | polymerase (RNA) I subunit D | DNA-directed RNA polymerase I subunit D | FLJ20616 | RPC16 | hRPA19 | DNA-directed RNA polymerases I and III subunit RPAC2 (isoform 1)

POLR1D: A Protein Implicated in Many Diseases

POLR1D (poly(ribonucleotide-conjugated) RNA-1 domain) is a protein that is expressed in various cell types of the human body, including stem cells, neurons, and immune cells. It is a key regulator of gene expression and has been implicated in the development and progression of many diseases, including cancer.

One of the unique features of POLR1D is its ability to interact with other proteins, both within and outside of the cell. This interaction allows it to regulate gene expression not only in the cell itself, but also in the surrounding environment, including other cells and extracellular matrix (ECM) components.

POLR1D has been shown to play a role in the regulation of stem cell proliferation and differentiation. It has been shown to repress the expression of genes involved in cell adhesion, migration, and the formation of tissues, such as neural stem cells and hematopoietic stem cells.

In addition to its role in stem cell biology, POLR1D has also been shown to be involved in the regulation of immune cell function. It has been shown to play a role in the regulation of T cell development and function, including the regulation of CD4+ and CD8+ T cell proliferation and differentiation.

Furthermore, POLR1D has been shown to be involved in the regulation of cell death, both in the context of programmed cell death (apoptosis) and in the context of non-programmed cell death (necrosis). This is important as it can be a potential drug target in diseases where cell death is abnormally high or where apoptosis is not a proper response to environmental stressors.

POLR1D has also been implicated in the development and progression of several diseases, including cancer. For example, it has been shown to be involved in the regulation of the development and progression of colon cancer. It has also been shown to play a role in the regulation of the development and progression of ovarian cancer.

In addition to its role in cancer, POLR1D has also been implicated in the regulation of a variety of other diseases, including neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

Despite the many advances in our understanding of POLR1D, the precise mechanisms that govern its function and regulation are not yet fully understood. However, it is clear that it plays an important role in the regulation of gene expression and that its dysfunction is implicated in the development and progression of many diseases.

In conclusion, POLR1D is a protein that has the potential to be a drug target or biomarker for a variety of diseases. Its unique ability to interact with other proteins and its involvement in the regulation of stem cell biology, immune cell function, and cell death make it an attractive candidate for further investigation. Further studies are needed to fully understand its function and regulation and to develop effective therapies based on its targeting.

Protein Name: RNA Polymerase I And III Subunit D

The "POLR1D Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about POLR1D comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

POLR1E | POLR1F | POLR1G | POLR1H | POLR1HASP | POLR2A | POLR2B | POLR2C | POLR2D | POLR2E | POLR2F | POLR2G | POLR2H | POLR2I | POLR2J | POLR2J2 | POLR2J3 | POLR2J4 | POLR2K | POLR2L | POLR2LP1 | POLR2M | POLR3A | POLR3B | POLR3C | POLR3D | POLR3E | POLR3F | POLR3G | POLR3GL | POLR3H | POLR3K | POLRMT | POLRMTP1 | Poly [ADP-ribose] polymerase | Polycomb Repressive Complex 1 (PRC1) | Polycomb Repressive Complex 2 | POM121 | POM121B | POM121C | POM121L12 | POM121L15P | POM121L1P | POM121L2 | POM121L4P | POM121L7P | POM121L8P | POM121L9P | POMC | POMGNT1 | POMGNT2 | POMK | POMP | POMT1 | POMT2 | POMZP3 | PON1 | PON2 | PON3 | POP1 | POP4 | POP5 | POP7 | POPDC2 | POPDC3 | POR | PORCN | POSTN | POT1 | POT1-AS1 | Potassium Channels | POTEA | POTEB | POTEB2 | POTEB3 | POTEC | POTED | POTEE | POTEF | POTEG | POTEH | POTEI | POTEJ | POTEKP | POTEM | POU-Domain transcription factors | POU1F1 | POU2AF1 | POU2AF2 | POU2AF3 | POU2F1 | POU2F2 | POU2F3 | POU3F1 | POU3F2 | POU3F3 | POU3F4 | POU4F1 | POU4F2 | POU4F3